That is a headline from Bloomberg
http://www.bloomberg.com/apps/news?pid=20601109&sid=auDOvthHzLnA.
They unfortunately forgot about Protalix (PLX)
Shire is a $52.45 a share stock and a market cap of $9 billion.
Protalix is a $8 a share stock and a market cap of $500 million.
To get to Genzyme's $16 billion market cap would be a 100% gain for Shire.
To get to Shire's market cap would be a 1000% gain for Protalix and to get to Genzyme's level from there would result in a 3,000% gain. (all figures are approximate)
So which stock would you want to gamble with?
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment